Award
Delivery Order #SPE2DR26FKAX0
Delivery Order for Xolair Autoinjector under Long-Term Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$7,848.84
Ceiling
$7,848.84
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 30, 2026
Identifier
SPE2DR26FKAX0
NAICS
424210
This award represents a delivery order contract granted to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical supply and management. The contract involves the procurement of Xolair 150 mg/ml autoinjectors, a specific pharmaceutical product used for therapeutic purposes. It is a component of a larger indefinite delivery vehicle (IDV) contract previously awarded to DMS Pharmaceutical Group, which supports the Pharmaceutical Product Vigilance Division by ensuring consistent pharmaceutical availability and safety management. The delivery order confirms a significant ongoing commitment to supplying vital medicines within a short-term period. The contract was acquired through a competitive bidding process as part of a robust multi-year IDV framework that commenced recently and extends over a decade. Performance under this delivery order will occur at Park Ridge, Illinois, with the work period limited to a few weeks, illustrating the government's agile procurement to meet immediate medical supply needs. There are no current key subcontractors or additional solicitation details noted for this specific delivery order.
Description
4571114256!XOLAIR 150 MG/ML AUTOINJECTORML